Hyderabad-Based Biological E Gets Approval For Pneumococcal Conjugate Vaccine
Streptococcus pneumonia infection remains one of the leading causes of death among children under five in India. Hyderabad-based pharmaceutical and
Read MoreStreptococcus pneumonia infection remains one of the leading causes of death among children under five in India. Hyderabad-based pharmaceutical and
Read MorePNEUMOCOCCAL VACCINE MARKET With 75 percent of current S&P 500 companies expected to disappear until 2027, according to research by
Read More